Journal of Medicinal Chemistry · 2024 · 15 citations · 32 references
MedicineCancer BiologyOncologyBiophotonicsMolecular ImagingMolecular OncologyCancer NanomedicinePhotochemistryPhotodynamic TherapyTargeted Cancer TherapyTargeted Imaging AgentsTumor ImagingCancer Photodynamic TherapyMolecular TargetingPhotosensitizersSinglet Oxygen FormationSinglet Oxygen GenerationSinglet Oxygen QuenchingTargeted Optical ImagingTumor Selectivity
Photodynamic therapy (PDT) is an innovative and promising method for treating tumors that has attracted significant interest but still faces several challenges, such as a lack of selectivity, deep penetration of light, and efficient ROS generation. To address these challenges, we optimized and synthesized a series of photosensitizers and successfully developed a heavy-atom-free near-infrared FUCL photosensitizer NFh-NMe-2. This photosensitizer can generate singlet oxygen ( 1 O 2 ) and induce cellular apoptosis under 808 nm light. For the safe ablation of microtumors in vivo, an activatable FUCL photosensitizer NFh-NTR was developed based on the overexpression of nitroreductase (NTR). NFh-NTR could be activated by NTR, leading to the release of the photosensitizer NFh-NMe-2, restoring the fluorescence signal, and effectively killing tumor cells under 808 nm light irradiation. This work opens new possibilities in the chemical design of an FUCL photosensitizer for cancer treatment.
32
Rebecca L. Siegel, Kimberly D. Miller, Nikita Sandeep Wagle et al. · CA A Cancer Journal for Clinicians · 2023 · 16.7K citations · Full text
Targeted photoredox catalysis in cancer cells
Huaiyi Huang, Samya Banerjee, Kangqiang Qiu et al. · Nature Chemistry · 2019 · 524 citations · Full text
Medicine, Cancer Biology, Oncology +12
Hypoxia-activated NIR photosensitizer anchoring in the mitochondria for photodynamic therapy
Feng Xu, Haidong Li, Qichao Yao et al. · Chemical Science · 2019 · 220 citations · Full text
Medicine, Cancer Biology, Oncology +15